X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1084) 1084
Publication (56) 56
Newsletter (22) 22
Book Review (19) 19
Book Chapter (6) 6
Government Document (2) 2
Book / eBook (1) 1
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (878) 878
flecainide (653) 653
male (514) 514
female (506) 506
cardiac & cardiovascular systems (396) 396
anti-arrhythmia agents - therapeutic use (386) 386
middle aged (381) 381
anti-arrhythmia agents - adverse effects (369) 369
flecainide - adverse effects (355) 355
flecainide - therapeutic use (318) 318
aged (317) 317
electrocardiography (301) 301
adult (255) 255
atrial fibrillation - drug therapy (240) 240
index medicus (235) 235
atrial fibrillation (213) 213
anti-arrhythmia agents - administration & dosage (163) 163
flecainide - administration & dosage (163) 163
arrhythmias, cardiac - drug therapy (151) 151
treatment outcome (140) 140
pharmacology & pharmacy (139) 139
animals (125) 125
sinus rhythm (124) 124
drug therapy (115) 115
arrhythmia (110) 110
amiodarone (106) 106
efficacy (104) 104
time factors (102) 102
cardiac arrhythmia (99) 99
follow-up studies (98) 98
tachycardia, supraventricular - drug therapy (98) 98
arrhythmias (97) 97
encainide (97) 97
tachycardia (96) 96
arrhythmias, cardiac - chemically induced (93) 93
therapy (93) 93
administration, oral (92) 92
propafenone (92) 92
antiarrhythmic drugs (87) 87
supraventricular tachycardia (87) 87
management (84) 84
heart rate - drug effects (80) 80
atrial fibrillation - physiopathology (79) 79
amiodarone - therapeutic use (78) 78
anti-arrhythmia agents - pharmacology (76) 76
dose-response relationship, drug (76) 76
anti-arrhythmia drugs (74) 74
flutter (74) 74
heart conduction system - drug effects (74) 74
flecainide acetate (73) 73
medicine, general & internal (72) 72
piperidines - adverse effects (72) 72
tachycardia - drug therapy (71) 71
electrocardiography - drug effects (69) 69
adolescent (68) 68
retrospective studies (68) 68
electrophysiology (64) 64
quinidine (64) 64
risk factors (64) 64
flecainide - pharmacology (62) 62
cardioversion (61) 61
aged, 80 and over (60) 60
piperidines - therapeutic use (60) 60
drug therapy, combination (59) 59
heart (59) 59
mortality (59) 59
electric countershock (58) 58
arrhythmias, cardiac - physiopathology (57) 57
infusions, intravenous (57) 57
prospective studies (55) 55
safety (55) 55
propafenone - therapeutic use (54) 54
atrial fibrillation - therapy (53) 53
care and treatment (53) 53
digoxin (53) 53
cardiac pacing, artificial (52) 52
double-blind method (52) 52
clinical trials as topic (51) 51
drugs (50) 50
atrial flutter - drug therapy (49) 49
cardiology (49) 49
fibrillation (49) 49
medicine & public health (49) 49
pregnancy (49) 49
cardiovascular (47) 47
conversion (47) 47
analysis (46) 46
propafenone - adverse effects (46) 46
amiodarone - adverse effects (45) 45
anilides - adverse effects (45) 45
recurrence (44) 44
anilides - therapeutic use (43) 43
proarrhythmia (43) 43
sotalol (43) 43
cardiovascular system (42) 42
electrical cardioversion (42) 42
heart conduction system - physiopathology (42) 42
atrial flutter (41) 41
evaluation (40) 40
flecainide - blood (40) 40
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1034) 1034
French (26) 26
German (21) 21
Italian (9) 9
Spanish (7) 7
Japanese (5) 5
Chinese (3) 3
Norwegian (2) 2
Polish (2) 2
Danish (1) 1
Dutch (1) 1
Finnish (1) 1
Hebrew (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2012, Volume 367, Issue 17, pp. 1587 - 1595
In this trial, patients with symptomatic paroxysmal atrial fibrillation were assigned to either radiofrequency ablation or antiarrhythmic drug therapy as... 
TRIAL | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | EFFICACY | SUBSTRATE | PULMONARY VEIN ABLATION | GUIDELINES | CATHETER ABLATION | COMPLICATIONS | SOCIETY | ANTIARRHYTHMIC-DRUG THERAPY | Follow-Up Studies | Atrial Fibrillation - drug therapy | Humans | Middle Aged | Propafenone - adverse effects | Cost of Illness | Male | Treatment Outcome | Anti-Arrhythmia Agents - therapeutic use | Atrial Fibrillation - surgery | Flecainide - adverse effects | Anti-Arrhythmia Agents - adverse effects | Atrial Flutter - diagnosis | Intention to Treat Analysis | Statistics, Nonparametric | Quality of Life | Female | Aged | Propafenone - therapeutic use | Catheter Ablation - adverse effects | Atrial Fibrillation - diagnosis | Electrocardiography, Ambulatory | Flecainide - therapeutic use | Care and treatment | Usage | Atrial fibrillation | Patient outcomes | Anti-arrhythmia drugs | Radiofrequency ablation | Dosage and administration | Drug therapy | Heart | Fees & charges | Cardiac arrhythmia | Stroke | Arrhythmia | Platelet-activating factor | Cardiovascular disease | Grants | Patients | Catheters | Manuscripts | Tamponade | Fibrillation | Motivation | Electrocardiography | Drug dosages | Antiarrhythmic agents | Veins & arteries | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Canadian Journal of Cardiology, ISSN 0828-282X, 2011, Volume 27, Issue 1, pp. 47 - 59
Abstract The goals of atrial fibrillation (AF) and atrial flutter (AFL) arrhythmia management are to alleviate patient symptoms, improve patient quality of... 
Cardiovascular | CARDIAC & CARDIOVASCULAR SYSTEMS | INTRAVENOUS AMIODARONE | RENIN-ANGIOTENSIN SYSTEM | TORSADE-DE-POINTES | POLYUNSATURATED FATTY-ACIDS | FOLLOW-UP | ANTIARRHYTHMIC THERAPY | CONGESTIVE-HEART-FAILURE | VENTRICULAR RATE CONTROL | SINUS RHYTHM | ELECTRICAL CARDIOVERSION | Digoxin - adverse effects | Calcium Channel Blockers - adverse effects | Humans | Middle Aged | Calcium Channel Blockers - therapeutic use | Catheter Ablation | Pacemaker, Artificial | Sotalol - therapeutic use | Dose-Response Relationship, Drug | Amiodarone - adverse effects | Heart Rate - drug effects | Sotalol - adverse effects | Amiodarone - therapeutic use | Adrenergic beta-Antagonists - adverse effects | Adult | Cardiac Output, Low - drug therapy | Drug Therapy, Combination | Digoxin - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Drug Administration Schedule | Atrial Fibrillation - drug therapy | Propafenone - adverse effects | Treatment Outcome | Anti-Arrhythmia Agents - therapeutic use | Cardiac Output, Low - complications | Amiodarone - analogs & derivatives | Flecainide - adverse effects | Canada | Myocardial Infarction - complications | Algorithms | Myocardial Infarction - drug therapy | Anti-Arrhythmia Agents - adverse effects | Atrial Fibrillation - etiology | Atrial Flutter - drug therapy | Aged | Propafenone - therapeutic use | Referral and Consultation | Flecainide - therapeutic use
Journal Article
International Journal of Cardiology, ISSN 0167-5273, 01/2019, Volume 274, pp. 170 - 174
We investigated whether rapid administration of a low dose of flecainide, either intratracheally or intravenously (IV), could accelerate conversion of atrial... 
Flecainide | Pharmacologic conversion | Atrial fibrillation | Pulmonary delivery | CARDIAC & CARDIOVASCULAR SYSTEMS | THERAPY | Dosage and administration
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 01/2011, Volume 57, Issue 3, pp. 313 - 321
Journal Article
Journal Article
Heart Rhythm, ISSN 1547-5271, 2016, Volume 14, Issue 4, pp. 564 - 569
Journal Article
Circulation: Arrhythmia and Electrophysiology, ISSN 1941-3149, 06/2015, Volume 8, Issue 3, pp. 633 - 642
Journal Article
Heart Rhythm, ISSN 1547-5271, 2013, Volume 10, Issue 4, pp. 542 - 547
Journal Article
Journal Article
Journal Article